These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 12568485

  • 1. Epidemiological studies in mucus hypersecretion.
    Vestbo J.
    Novartis Found Symp; 2002; 248():3-12; discussion 12-9, 277-82. PubMed ID: 12568485
    [Abstract] [Full Text] [Related]

  • 2. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ.
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
    Disse B.
    Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
    [Abstract] [Full Text] [Related]

  • 4. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
    Vestbo J, Prescott E, Lange P.
    Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
    [Abstract] [Full Text] [Related]

  • 5. Epidemiology of bronchial hypersecretion: recent studies.
    Pride NB.
    Eur J Respir Dis Suppl; 1987 May; 153():13-8. PubMed ID: 3322856
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
    Crisafulli E, Coletti O, Costi S, Zanasi E, Lorenzi C, Lucic S, Fabbri LM, Bertini M, Clini EM.
    Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
    [Abstract] [Full Text] [Related]

  • 7. Mucin-producing elements and inflammatory cells.
    Jeffery P, Zhu J.
    Novartis Found Symp; 2002 Sep; 248():51-68; discussion 68-75, 277-82. PubMed ID: 12568488
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chronic mucus hypersecretion, exacerbations and natural history of COPD.
    Vestbo J.
    Exp Lung Res; 2005 Sep; 31 Suppl 1():63-5. PubMed ID: 16395861
    [No Abstract] [Full Text] [Related]

  • 11. Risk factors for chronic mucus hypersecretion in individuals with and without COPD: influence of smoking and job exposure on CMH.
    Dijkstra AE, de Jong K, Boezen HM, Kromhout H, Vermeulen R, Groen HJ, Postma DS, Vonk JM.
    Occup Environ Med; 2014 May; 71(5):346-52. PubMed ID: 24642640
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased expression of human calcium-activated chloride channel 1 is correlated with mucus overproduction in the airways of Chinese patients with chronic obstructive pulmonary disease.
    Wang K, Feng YL, Wen FQ, Chen XR, Ou XM, Xu D, Yang J, Deng ZP.
    Chin Med J (Engl); 2007 Jun 20; 120(12):1051-7. PubMed ID: 17637221
    [Abstract] [Full Text] [Related]

  • 14. Chronic mucus hypersecretion: a marker of asthma in young adults?
    Ulrik CS, von Linstow ML, Nepper-Christensen S, Porsbjerg C, Backer V.
    Respir Med; 2005 Dec 20; 99(12):1576-82. PubMed ID: 16291078
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The overlap syndrome of asthma and COPD: what are its features and how important is it?
    Gibson PG, Simpson JL.
    Thorax; 2009 Aug 20; 64(8):728-35. PubMed ID: 19638566
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.